Prothena Corporation plc - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
PRTA Nasdaq 2836 www.prothena.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Prothena Corporation plc

4 Alzheimer's Drug Stocks to Watch on World Alzheimer's Day - Sep 21st, 2026 10:40 am
Prothena to Participate in the H.C. Wainwright 28th Annual Global Investment Conference - Sep 9th, 2026 2:05 pm
Real Parkinson’s Disease Hope from Jupiter Neurosciences - Aug 19th, 2026 10:32 am
KMDA or PRTA: Which Is the Better Value Stock Right Now? - Aug 14th, 2026 9:40 am
PRTA's Q2 Loss Narrower Than Expected, Pipeline Progress in Focus - Aug 7th, 2026 11:41 am
Prothena (PRTA) Reports Q2 Loss, Misses Revenue Estimates - Aug 6th, 2026 5:10 pm
Prothena Reports Second Quarter 2026 Financial Results and Business Highlights - Aug 6th, 2026 2:05 pm
Prothena to Report Second Quarter 2026 Financial Results on August 6 - Jul 30th, 2026 2:05 pm
PRTA Stock Rises Nearly 11% in Six Months: What's Driving It? - Jul 9th, 2026 9:38 am
SRPT or PRTA: Which Is the Better Value Stock Right Now? - Jun 24th, 2026 9:40 am
High Insider Ownership Growth Stocks To Watch In May 2026 - May 28th, 2026 11:35 am
Earnings Beat: Prothena Corporation plc Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models - May 11th, 2026 7:17 am
Prothena Posts Q1 Earnings as Revenues Surge on Milestone Payment - May 8th, 2026 8:36 am